U.S. FDA approves first treatment for drug-resistant post-transplant infection
The approval is for Cytomegalovirus, a type of Herpes virus
The approval is for Cytomegalovirus, a type of Herpes virus
Taluka level transplant centre will add convenience to patients from rural areas
The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017
The transplant procedure was completed in under two hours
It adds Rezurock (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD)
The boy becomes India’s youngest recipient to undergo bilateral lung transplantation.
The hospital works in close collaboration with the Network for Organ Sharing and the National Organ & Tissue Transplant Organisation (NOTTO) and it is amongst the very few hospitals doing ABO-incompatible transplant
The MoU was signed on World Organ Donation Day which falls on August 13
Subscribe To Our Newsletter & Stay Updated